Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

GE Healthcare Launches New illustra™ Ready-To-Go™ GenomiPhi™ Kits

Published: Tuesday, July 24, 2012
Last Updated: Tuesday, July 24, 2012
Bookmark and Share
Easy to use, high yield kits for whole genome amplification which can be stored at the bench.

GE Healthcare’s new illustra™ Ready-To-Go™ GenomiPhi™ kits provide researchers with a pre-dispensed, room temperature stable formulation for whole genome amplification, enabling a simplified workflow for obtaining large amounts of high quality DNA from small genomic DNA samples.

The new kits also deliver improved yields over the current GenomiPhi kits.

GE Healthcare is the leader in DNA amplification based on the unique Phi29 DNA polymerase, employing the enzyme’s exceptional fidelity and processivity to prepare DNA for sequencing and genomic applications using the smallest of samples.

Previous GenomiPhi kits contain liquid enzyme formulations that require storage at -80°C degrees.

The new kits incorporate GE Healthcare’s proprietary Ready-To-Go stabilization technology which delivers single-dose reaction mixes in a solid format that can be stored for months at the bench without the need for refrigeration.

The new illustra Ready-To-Go GenomiPhi kits are available in two formats; Ready-To-Go GenomiPhi V3 improves upon the current GenomiPhi V2 kit with more than double the previous DNA yield, whilst Ready-To-Go GenomiPhi HY is specifically developed for high yield requirements, achieving 40 to 60 µg DNA yield from just 10 ng of starting DNA.

Both kits are available in convenient 8-well strips or in 96-well plate formats.

illustra Ready-To-Go GenomiPhi kits can be used to amplify DNA from blood lysates and dried blood spots.

A protocol has been developed for amplification from Whatman™ FTA card punches with minimal handling, thus enabling a streamlined, efficient workflow for sample collection and analysis.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

GE Healthcare Licenses CRISPR Gene Engineering Technology Patents
Agreement will drive bioscience research by enabling development of novel Dharmacon genome engineering toolsets.
Tuesday, December 09, 2014
GE Licenses CRISPR Gene Engineering Technology Patents From Broad Institute
Agreement will drive bioscience research by enabling development of novel Dharmacon genome engineering toolsets.
Thursday, December 04, 2014
GE Healthcare to Collaborate with GlaxoSmithKline on Commercial Oncology Testing
The collaboration aims to improve access to diagnostic testing for cancer patients by establishing a network of clinical laboratories to identify genetic mutations associated with different tumour types.
Tuesday, September 30, 2014
GE Healthcare Scientist Paired with Cardiff MP to Share Insights on Cell Therapy, Science and Policy-Making
Dr. Michelle Janas from GE Healthcare Life Sciences visited Jenny Willott MP at the House of Commons for a “Week in Westminster” as part of a unique ‘pairing’ scheme run by the Royal Society.
Thursday, November 15, 2012
GE Healthcare to Invest $1 Billion in New Oncology Solutions
Expanding advanced cancer diagnostic and molecular imaging capabilities.
Saturday, September 17, 2011
GE Healthcare Appoints Kieran Murphy as Life Sciences CEO, Successor to Peter Ehrenheim
On 1 April 2011, Kieran Murphy will be promoted to succeed current Life Sciences President and CEO Peter Ehrenheim who will retire from GE after a transition period on July 31 2011.
Tuesday, February 22, 2011
IN Cell Image Competition 2009/2010 Voting Opens
Vote for your favorite image and receive a complementary 2010 calendar!
Tuesday, December 01, 2009
GE Launches $250 Million Healthymagination Fund
New equity investment fund to invest in high potential healthcare technology companies; Supports GE’s global Healthymagination initiative, focusing on cost, access and quality.
Monday, October 26, 2009
GE Healthcare Forms Strategic Alliance with FUJIFILM in Life Sciences
Under the alliance, Fujifilm will develop, manufacture and supply advanced biomolecular imaging systems to GE Healthcare.
Thursday, June 04, 2009
GE Healthcare Forms Strategic Alliance with FUJIFILM in Life Sciences
GE Healthcare announced that it has entered into a Strategic Alliance Agreement with FUJIFILM Corporation. Under the alliance, Fujifilm will develop, manufacture and supply advanced biomolecular imaging systems to GE Healthcare.
Thursday, May 28, 2009
Winners of GE Healthcare’s IN Cell Image Competition Announced
Each of the three winners, from Asia, Europe and North America, will be rewarded with a trip to New York City in March.
Wednesday, January 14, 2009
Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Cancer Gene-Drug Combinations Ripe for Precision Medicine
The study aims to expand the number of cancer gene mutations that can be paired with a precision therapy.
Targeting BRAF Mutations in Thyroid Cancer
Treating metastatic thyroid cancer patients harboring a BRAF mutation with vemurafenib showed anti-tumor activity in a third of patients.
Colon Cancer Blocked in Mice
Case Western Reserve University Researchers block common type of colon cancer tumour in mice, laying groundwork for human clinical trial.
Cancer Related Immune Response Genes Uncovered
Researchers at the SBP have identified over 100 new genetic regions that affect the immune response to cancer.
New Therapeutic Targets For Small Cell Lung Cancer Identified
Researchers at UTSW Medical Center have identified a protein termed ASCL1 that is essential to the development of small cell lung cancer.
Deciphering Inactive X Chromosomes
Untangling the Barr body of inactive X chromosomes valuable for understanding chromosome structure and gene expression.
Micro Disease-Detecting Sensor Created
Researchers at McMaster University have created a microscopic disease-detecting sensor that can turn on to detect trace amounts of substances.
Liquid Biopsies Treating Ovarian Cancer
Researchers have discovered a promising monitor and treat recurrence of ovarian cancer. Detecting cancer long before tumours reappear.
Uncovering a New Principle in Chemotherapy Resistance in Breast Cancer
The NIH study has revealed an entirely unexpected process for acquiring drug resistance that bypasses the need to re-establish DNA damage repair in breast cancers that have mutant BRCA1 or BRCA2 genes.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!